ACE inhibitors and the risk of acute pancreatitis : a population-based case–control study
Kuoppala, Jaana; Enlund, Hannes; Pulkkinen, Jukka; Kastarinen, Helena; Jyrkkä, Johanna; Happonen, Pertti; Paajanen, Hannu E. K. (2017-07)
Tätä artikkelia/julkaisua ei ole tallennettu Julkariin. Julkaisun tiedoissa voi kuitenkin olla linkki toisaalle tallennettuun artikkeliin/julkaisuun.
Kuoppala, Jaana
Enlund, Hannes
Pulkkinen, Jukka
Kastarinen, Helena
Jyrkkä, Johanna
Happonen, Pertti
Paajanen, Hannu E. K.
John Wiley and Sons
07 / 2017
Pharmacoepidemiology and Drug Safety : 7
Tiivistelmä
Purpose: The aim of this study was to examine the association between angiotensin converting enzyme (ACE) inhibitor use and the risk of acute pancreatitis. Methods: Information on all 4966 cases hospitalized in 2008–2010 for acute pancreatitis was retrieved from the Finnish national registers on hospital discharges and prescriptions. A total of 24 788 age and sex-matched population-based controls were randomly selected using density sampling. ACE inhibitor use between 1 January 2003 and the index date were determined by the date of hospitalization for acute pancreatitis among the cases. The incidence rate ratios of acute pancreatitis not diagnosed as biliary or alcohol-induced were modeled by conditional logistic regression and adjusted for comorbidities. Results: A total of 1276 (26%) cases and 3946 (16%) controls had been exposed to ACE inhibitors. The use of ACE inhibitors was associated with an increased incidence rate of acute pancreatitis (odds ratio [OR] 1.76, 95% confidence interval [CI] 1.59–1.95). The increase was slightly higher among current new users (OR 1.86, 95%CI 1.65–2.09) and somewhat lower among current prevalent (OR 1.54, 95%CI 1.35–1.75) and former users (OR 1.51, 95%CI 1.31–1.74). Conclusions: Angiotensin converting enzyme inhibitor use seems to be associated with a moderately increased risk of acute pancreatitis.
Kokoelmat
- Artikkelit [186]